請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/9556完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 丁志音 | |
| dc.contributor.author | Huei-Yin Tsai | en |
| dc.contributor.author | 蔡慧茵 | zh_TW |
| dc.date.accessioned | 2021-05-20T20:28:29Z | - |
| dc.date.available | 2008-09-11 | |
| dc.date.available | 2021-05-20T20:28:29Z | - |
| dc.date.copyright | 2008-09-11 | |
| dc.date.issued | 2008 | |
| dc.date.submitted | 2008-08-01 | |
| dc.identifier.citation | 中文部分
1.林克明:藥與毒的挑戰-迎接成癮醫學時代的來臨。國家衛生研究院電子報,2007;第227期。 2.張嫚純、丁志音:成癮藥物使用情境脈絡與HIV感染關聯之初探。台灣衛誌 2006;25(6),462-473。 3.陳政惠:台南監所男性靜脈注射藥癮者感染愛滋病毒之危險因素探討。台南:國立成功大學醫學院公共衛生研究所碩士論文,2006。 4.許淑雲:靜脈注射藥癮者感染愛滋病毒之危險行為探討。疫情報導2007;23(10),549-559。 5.劉玉山、王佳惠、郭乃文:醫院藥師提供用藥指導之態度與行為意向。北市醫學雜誌2007;4(2),73-87。 6.趙運植:以計畫行為理論探討某單位士官兵的愛滋相關知識與保險套使用行為意向。台北:國防大學國防醫學院公共衛生學研究所碩士論文,2003。 7.王懋雲:態度-行為形成理論與研究法。台北:衛生教育專題研究,1998。 8.黃鈴晃:以社會行銷概念探討毒品減害計畫之推展。高雄:國立中山大學高階經營碩士論文,2006。 9.佩特•德寧、珍妮•利特、艾迪娜•葛利曼著、謝菊英、蔡春美、管少彬譯:挑戰成癮觀點-減害治療模式。台北:張老師文化,2007。 10.衛生署疾病管制局:疾病管制局網頁/愛滋病主題/國內疫情報導/統計資料。http://www.cdc.gov.tw/lp.asp?ctNode=1095&CtUnit=434&BaseDSD=7&mp=220。引用2008/1/10。 11.衛生署疾病管制局:毒品病患愛滋減害試辦計畫(核定本),2005。 12.衛生署疾病管制局:96年減刑藥癮世代血液傳染病和相關行為追蹤計畫,2007。 13.衛生署疾病管制局:95年科技研究計畫,2006。 14.衛生署疾病管制局:95年擴大辦理清潔針具計畫說明會暨第一次中區防疫會議,2006。 15.衛生署疾病管制局:全國清潔針具週報表,引用2008/1/4。 16.陳松欽:北市主動出擊訪管管局,藥師周刊電子報,2007;第1511期。 17.舊針具回收率低,議員:愛滋漏洞。自由時報,2008.05.16。 18.中央健康保險局網站(http://www.nhi.gov.tw)。 英文部分 1.Ajzen I. The theory of planned behaveior. Organ Behav Hum Decis Process 1991; 50(2): 179-211. 2.Montaño DE, Kasprzyk D. The theory of reasoned action and the theory of planned behavior. Health Behavior and Health education 1997; p67-98. 3.Madden TJ, Ellen PS, Ajzen I. A comparison of the theory of planed behaveior and the theory of reasoned action. Pers Soc Psychol Bull 1992; 18(1): 3-9. 4.Walker A, Watson M, Grimshaw J, Bond C. Applying the theory of planned behaviour to pharmacists’ beliefs and intentions about the treatment of vaginal candidiasis with non-prescription medicines. Fam Pract 2004; 21(6): 670-676. 5.Rácz J, Gyarmathy VA, Neaigus A, Ujhelyi E. Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest. AIDS Care 2007; 19(1): 59-66. 6.Mashburn JH. Using the theory of planned behavior to predict Texas community pharmacists' willingness to provide sterile syringes to known or suspected intravenous drug users. Unpublished doctoral dissertation, 2003. 7.Wodak A. Twelve lessons from two decades of harm reduction. Conference on methadone maintenance treatment, Taipei, Taiwan, Jan 22, 2008. 8.Wodak A. Opioid dependence treatment & HIV/AIDS management. Conference on methadone maintenance treatment, Taipei, Taiwan, Jan 22, 2008. 9.Sheridan J, Henderson C, Greenhill N, and Smith A. Pharmacy-based needle exchange in New Zealand: a review of services. Harm Reduction Journal 2005; 2:10. 10.Clarke K, Sheridan J, Griffiths P, Nobel A, Williamson S, Taylor C. Pharmacy Needle Excgange: do clients and community pharmacists have matching perceptions? Pharm J 2001; 266: 553-556. 11.Sheridan J, Strang J, Taylor C, Barber N. HIV prevention and for drug misusers: a national study of community pharmacists’ attitudes and their involvement in service specific training. Addiction 1997; 92(12):1737-1748. 12.Gibson DR, Brand R, Anderson K, Kahn JG, Perales D, Guydish J. Two- to Sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. JAIDS 2002; 31(2): 237-242. 13.Fisher DG, Fenaughty AM, Cagle HH, and Wells RS. Needle exchange and injection drug use frequency: a randomized clinical trial. JAIDS 2003; 33:199-205. 14.Rose V. Expanding access to syringes. Focus 2007; 22(3): 1-8. 15.Taussing JA, Weinstein B, Burris S and Jones TS. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. AIDS 2000; 14 (suppl 1): 47-51. 16.Aceijas C, Stimson GV, Hickman M, Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004; 18(17): 2295-2343. 17.Taussig J, Junge B, Burris S, Jones TS, Sterk CE. Individual and structural influences shaping pharmacists’ decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc. 2002; 42(suppl 2): 40-45. 18.Watson L, Bond C and Gault C. A survey of community pharmacists on prevention of HIV and hepatitis B and C: current practice and attitudes in Grampian. J Public Health Med 2003; 25(1): 13-18. 19.Reich W, Compton WM, Horton JC, Cottler LB, Cunningham-Williams RM, Booth R, Singer M, Leukefeld C, Fink J, Stopka T, Corsi KF, Tindall MS. Pharmacist ambivalence about sale of syringes to injection drug users. J Am Pharm Assoc 2002; 42 (suppl 2): 52-57. 20.Harbke CR, Fisher DG, Cagle HH, Trubatch BN, Fenaughty AM, Johnson ME. Telephone survey of Alaskan pharmacists’ nonprescription needle-selling practices. J Urban Health 2000; 77(1): 113-120. 21.Matheson C, Bond CM & Pitcairn J. Community pharmacy services for drug misusers in Scoland: what difference does 5 years make? Addiction 2002; 97(11): 1405-1411. 22.Deibert RJ, Goldbaum G, Parker TR, Hagan H, Marks R, Hanrahan M, Thiede H. Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003. Am J Public Health 2006; 96(8): 1347-1353. 23.Wood E, Kerr T, Small W, Jones J, Schechter MT, Tyndall MW. The impact of a police presence on access to needle exchange programs. J Acquir Immune Defic Syndr 2003; 34(1): 116-118. 24.Marks RW, Hanrahan M, Goldbaum G, Thiede H, Wood RW, Deibert R. Pharmacy syringe access and syringe disposal: IDU disease prevention in Seattle. National HIV prevention conference, Atlanta, Georgia, USA-July 27 -30, 2003; abstract no. T3-C1401. 25.USA CDC. Access to sterile syringe. Available at: http://www.cdc.gov/idu/facts/aed_idu_acc.htm. Accessed November 22, 2007. 26.USA CDC. Pharmacy sales of sterile syringes. Available at: http://www.cdc.gov/idu/facts/aed_idu_phar.htm. Accessed November 22, 2007. 27.USA CDC. State and local policies regarding IDU’s access to sterile syringes. Available at: http://www.cdc.gov/idu/facts/aed_idu_pol.htm. Accessed November 22, 2007. 28.WHO. HIV prevention, treatment and care for injecting drug users and prisoners. Available at: http://www.who.int/hiv/topics/idu/en/index.html. Accessed March 18, 2008 29.WHO. Effectiveness of sterile needle and syringe programming in reduction HIV/AIDS among injecting drug users. Available at: http://www.who.int/hiv/pub/prev_care/en/effectivenesssterileneedle. Accessed March 18, 2008. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/9556 | - |
| dc.description.abstract | 靜脈藥癮者因為共用注射針具及相關用品之行為而感染愛滋病是現階段愛滋防治工作的重要挑戰。使靜脈藥癮者能不受限制的獲得清潔針具是一項重要且最符合經濟效益的重要公共衛生措施,我國的減害計畫核心內容之一「清潔針具計畫」於2006年全面推展,以社區藥局為主要執行點,為擴增涵蓋率及提供可近性服務內容,瞭解社區藥局提供或販賣清潔的意願有其必要性;而已在計畫之列的社區藥局在實務操作上所面臨的困難及建議,可以做為政策修正之參考。
本研究目的即在於了解社區藥局對於參與清潔針具計畫的意願及其認知與實務經驗,資料收集時間為97年3月11日起為期4週。利用郵寄方式,回收率為20.8%,以台灣北區四縣市的社區藥局為主要研究對象,利用結構性問卷收集社會人口學、提供或販賣清潔針具給靜脈藥癮者的意願態度、實務經驗、政策認知等資料。應用計畫行為理論(Theory of Planned Behavior, TPB)的概念和架構來初步探討他們的意願;並描述社區藥局對於所提供減害服務的實際執行經驗。 主要發現如下:(1)對於提供或販賣清潔針具給靜脈藥癮者傾向「非常願意與願意」的有43.3%;(2)影響社區藥局意願態度的因素,包括「會降低疾病傳染(例如愛滋病及肝炎)」的認知、「社區鄰居」的看法、「個人對於提供針具予靜脈藥癮者的倫理或道德的主觀感受」的考量;(3)「態度」愈正向、「主觀規範」影響愈小與「覺知的行為控制」考量愈少,則參與意願愈高。(4)「從不曾加入」清潔針具計畫是安全的考量;「曾經加入,後來退出」是店內生意繁忙;社區藥局認為執行最感困難為轉介服務及衞教無法送達、針具回收;建議加強宣導及毒品教育。 根據結果建議:(1)教育與召募:強調清潔針具計畫的公共衛生意義,喚起社區藥局的社會責任和參與的熱情,以擴大涵蓋率;(2)實務輔導:政府與社區藥局建立合作夥伴關係,瞭解其需要、提供訓練與支持,以提升品質;(3)提供誘因,解決社區藥局的社會結構性障礙,例如對安全考量的疑慮。 | zh_TW |
| dc.description.abstract | HIV infection among injection drug users (IDUs) due to sharing needles and syringes poses great challenge for the current HIV prevention tasks, and unlimited provision of sterile needles and syringes to IDUs therefore constitutes the most cost-effective measure of public health. “Needle and Syringe Program”, one of the core programs of the domestic Harm Reduction Program, has been initiated nationwide since 2006. Community pharmacies are chosen to be the main locations to execute the program. To increase the program coverage and provide more accessible services, it is necessary to understand the responses and willingness of pharmacists in proving and selling clean needles and syringes. Of greater significance, barriers encountered by community pharmacists who have ever participated or are participating in the program should be explored to provide feedbacks to current program implementation.
Based on the Theory of Planned Behavior, this study aims to examine the perceptions, cognitions, and behavioral characteristics of current program participants, previous participants, and non-participants. Special experiences from previous and current participation were particularly emphasized to respond to current policy. In March 2008, self-administered questionnaires were distributed, mainly through mailing, to employees/employers of community pharmacies located in four counties of northern part of Taiwan. A total of 178 valid questionnaires were collected, which made a final response rate of 20.8%. The main findings are as follows: (1) 43.3% of the surveyed pharmacies were “very willing or willing” to provide and sell sterile needles and syringes to IDUs, (2) The major attitudinal factors affecting participation are “the program can contribute to the reduction of infections such as HIV and hepatitis, “the reactions of neighborhoods”, and “moral and ethic consideration in the provision of needles and syringes to IDUs”. (3) The more positive of the “attitudes” and the less influenced by the “subjective norms” and “perceived behavioral control” the more likely a pharmacist was willing to join the program, and (4) For non participants, safety was their primary concern, and for previous participants, which was “demanding and heavy work load.” The major difficulties encountered in the execution of the program were referral to other areas of services, ineffective delivery of health education, collection of used needles and syringes. They suggested more efforts be made to enhance campaign and drug education. The following aspects of suggestions are proposed based on the above findings: (1) To increase the coverage of the program through more intensive recruitment and training which emphasize public health implications of the program, and by so doing to raise the social responsibility and passion of community pharmacies and. (2) The government should provide supports and consultations, and build partnerships with community pharmacies to understand their needs and improve their quality of services. (3) Incentives should be provided to reduce the socio-structural barriers faced by community pharmacies, such as their concerns of safety. | en |
| dc.description.provenance | Made available in DSpace on 2021-05-20T20:28:29Z (GMT). No. of bitstreams: 1 ntu-97-P95845104-1.pdf: 985658 bytes, checksum: ea0b048035e761a6afda50cbe88c5e05 (MD5) Previous issue date: 2008 | en |
| dc.description.tableofcontents | 誌謝...................................................... i
中文摘要..................................................ii 英文摘要..................................................iv 目錄......................................................vi 圖目錄..................................................viii 表目錄....................................................ix 第一章 緒論..............................................1 第一節 研究背景..........................................1 第二節 研究動機與重要性..................................3 第三節 研究目的..........................................4 第二章 文獻探討..........................................5 第一節 減害政策..........................................5 第二節 靜脈藥癮者與清潔針具計畫..........................7 第三節 減害政策下社區藥局的公共衛生角色.................10 第四節 研究理論依據.....................................13 第三章 研究方法.........................................19 第一節 研究架構.........................................19 第二節 研究對象.........................................20 第三節 研究工具.........................................20 第四節 資料收集及處理...................................25 第五節 資料分析.........................................27 第四章 研究結果.........................................29 第一節 研究樣本特質.....................................29 第二節 研究變項描述性統計...............................30 第三節 雙變項分析.......................................44 第四節 社區藥局提供或販賣清潔針具意願的相關影響因素.....49 第五節 執行困難與建議...................................52 第五章 討論.............................................59 第一節 以社區為基礎的清潔針具計畫.......................59 第二節 社區藥局的困境...................................61 第三節 提升知識,開發教育訓練...........................63 第四節 研究限制.........................................64 第六章 結論與建議.......................................65 第一節 結論.............................................65 第二節 建議.............................................66 參考文獻..................................................68 附錄......................................................74 | |
| dc.language.iso | zh-TW | |
| dc.title | 社區藥局對於參與清潔針具計畫的意願及其認知與實務經驗 | zh_TW |
| dc.title | Willingness to and the experiences of Participating in Needle Syringe Programs among Community Pharmacies | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 96-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 蔡慈儀,王永衛 | |
| dc.subject.keyword | 靜脈藥癮者,清潔針具計畫,社區藥局,計畫行為理論, | zh_TW |
| dc.subject.keyword | injection drug users,Needle and Syringe Program,community pharmacy,Theory of Planned Behavior, | en |
| dc.relation.page | 78 | |
| dc.rights.note | 同意授權(全球公開) | |
| dc.date.accepted | 2008-08-01 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 衛生政策與管理研究所 | zh_TW |
| 顯示於系所單位: | 健康政策與管理研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-97-1.pdf | 962.56 kB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
